NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Healthcare Plans · USD

Humana Inc. (HUM) Stock Analysis

Humana Inc. (HUM) is a Healthcare Plans stock listed on NYSE and quoted in US Dollar.

HUM

$401.54

−$4.98 (−1.23%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HUM with… →

HUM Key Statistics

As of Sep 4, 2026
Trading
Open
$404.34
Previous Close
$406.52
Day's Range
398.59–409.06
52-Week Range
163.11–428.88
Volume
783.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.74
Valuation
Market Cap
$48.22B
P/E Ratio
38.46
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
24.24
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.36
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.33
EPS (ttm)Profit attributable to each share over the last twelve months.
10.44
Financials (FY)
Revenue (FY)
$129.66B+10.11%
Net Income (FY)
$1.19B−1.57%
Profit marginThe share of revenue left as profit after all costs and taxes.
0.88%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
120.08M
1-Year Return
+30.56%
Dividend and dates
Dividend
$3.54+0.87%
Ex-Dividend Date
October 30, 2026
Earnings Date
November 6, 2026
Avg Volume
1.36M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HUM Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+57.94%
2025+2.36%
2024−43.96%
2023−9.94%
2022+11.15%
2021+13.80%
2020+12.71%
2019+28.94%
2018+16.27%
2017+22.60%
2016 (partial year)+15.04%

As of September 4, 2026.

HUM Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$129.66B$1.19B0.9%
2024$117.76B$1.21B1.0%
2023$106.37B$2.49B2.3%
2022$92.87B$2.81B3.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$129.66B——$1.19B0.9%
2024$117.76B——$1.21B1.0%
2023$106.37B——$2.49B2.3%
2022$92.87B——$2.81B3.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

HUM Dividend History

$3.54+0.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.772—
2025$3.544+0.0%
2024$3.544+0.0%
2023$3.544+12.3%
YearDividends per sharePaymentsChange
2026 (partial year)$1.772—
2025$3.544+0.0%
2024$3.544+0.0%
2023$3.544+12.3%
2022$3.154+12.6%
2021$2.804+12.0%
2020$2.504+13.6%
2019$2.204+10.0%
2018$2.004+5.8%
2017$1.895+551.7%
2016$0.291—

Most recent payment: $0.89 per share, ex-dividend June 26, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

HUM Valuation vs Healthcare Plans Median

Median of 11 stocks
MetricHUMHealthcare Plans medianvs median
P/E38.4625.6650% above
P/S ratio0.330.4425% below
Profit margin0.88%1.18%0.3 pts below

Medians across 11 Healthcare Plans stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Humana Inc. (HUM) at $48.22B. It is classified in the Healthcare Plans industry, within the Healthcare sector. Headcount on file is 67,060.

HUM last closed at $401.54 on September 4, 2026. That is −$4.98 (−1.23%) against the previous close. The 52-week range on file runs from $163.11 to $428.88. The latest close sits 146.18% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $129.66B. That is +10.11% against the prior fiscal year, when revenue was $117.76B. Net income for the same year was $1.19B. That is −1.57% against the prior fiscal year. Profit margin runs at 0.88%. That is 0.3 percentage points below the Healthcare Plans median of 1.18%. Earnings per share on a trailing basis come to 10.44.

Across the 4 fiscal years on file, revenue moves from $92.87B in 2022 to $129.66B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 38.46. That is 49.88% above the Healthcare Plans median of 25.66. On forward earnings the ratio is 24.24. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.36. Measured against sales, the shares trade at 0.33 times revenue. On price-to-sales that is 24.68% below the Healthcare Plans median of 0.44. 11 Healthcare Plans companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned +30.56%. Across 10 years the annualized return works out at +9.44%. The reported beta is 0.75. Daily returns over the trailing 10 years annualize to a volatility of 34.6%.

Growth & Income

The trailing dividend yield is 0.87%. That is 1.3 percentage points below the Healthcare Plans median yield of 2.18%. The indicated annual rate is $3.54 a share. The ex-dividend date on file is October 30, 2026. Dividends are recorded for 11 calendar years; 2026 shows 2 payments totalling $1.77 a share. The year before, 2025, totalled $3.54 a share.

2026 is still running; the price is +57.94% year to date. Across the complete calendar years on file, 2019 returned +28.94% and 2024 returned −43.96%. Of the 9 complete calendar years on file, 7 finished higher.

Peer Comparison

Humana Inc. (HUM) operates in the Healthcare Plans industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Humana Inc. HUM $48.22B 38.5
UnitedHealth Group Incorporated UNH $356.47B 25.5
CVS Health Corporation CVS $123.73B 25.7
Elevance Health, Inc. ELV $88.37B 18.4

The Healthcare Plans industry average P/E ratio is 25.7x. Humana Inc. trades at a P/E of 38.5.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Healthcare Plans Stocks

UNH

UnitedHealth Group Incorporated

$356.47B

 CVS

CVS Health Corporation

$123.73B

 ELV

Elevance Health, Inc.

$88.37B

 CI

The Cigna Group

$74.65B

 CNC

Centene Corporation

$33.12B

 MOH

Molina Healthcare, Inc.

$10.48B
View all Healthcare Plans stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 NVS

Novartis AG

$304.10B
View all Healthcare stocks →

About Humana Inc.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Visit website →